The University of Chicago Header Logo

Connection

Tong-Chuan He to Proto-Oncogene Proteins

This is a "connection" page, showing publications Tong-Chuan He has written about Proto-Oncogene Proteins.
Connection Strength

0.323
  1. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J Biol Chem. 1995 May 12; 270(19):11055-61.
    View in: PubMed
    Score: 0.096
  2. The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells. J Biol Chem. 1994 Jul 15; 269(28):18291-4.
    View in: PubMed
    Score: 0.090
  3. Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
    View in: PubMed
    Score: 0.041
  4. The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera. J Biol Chem. 1996 Jul 12; 271(28):16472-6.
    View in: PubMed
    Score: 0.026
  5. Erythropoietin-dependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem. 1995 Jun 16; 270(24):14500-4.
    View in: PubMed
    Score: 0.024
  6. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem Biophys Res Commun. 1994 Oct 14; 204(1):278-83.
    View in: PubMed
    Score: 0.023
  7. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J Biol Chem. 1994 Aug 26; 269(34):21411-4.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.